
View larger version (76K):
[in a new window]
|
Fig. 1. Intracellular localization of human HP1 subtypes. (A) Localization of human
HP1 subtypes in interphase nuclei. HeLa cells transiently expressing
YFP-HP1 (a-e), YFP-HP1ß (f-j), or YFP-HP1 (k-o) were fixed,
and centromeres and PML nuclear bodies were viewed by indirect
immunofluorescent staining. (b,g,l) centromeres, (c,h,m) YFP-HP1 and (d,i,n)
PML nuclear bodies in the same cells. Merged images in a, f and k, of HP1
(green) and of centromeres (red) and in e, j and o for HP1 (green) and the PML
nuclear bodies (red). Bar, 10 µm. (B) Metaphase localization of HP1
subtypes. HeLa cells transiently expressing YFP-HP1 (a-c),
YFP-HP1ß (d-f), or YFP-HP1 (g-i) were fixed and stained with DAPI
(a, d and g). (c, f, and i) Merged images of HP1 (green) and DAPI (red). Bar,
10 µm. (C) HeLa cells transiently expressing YFP-HP1 were arrested
at mitosis by treatment with 650 nM nocodazole for 8 hours. Centromeres were
stained with human antisera that recognizes CENP-A, CENP-B, and CENP-C
proteins (Masumoto et al.,
1989 ). (a) DAPI, (b) YFP-HP1 and (c) centromeres. (d) A
merged image of DAPI (blue), YFP-HP1 (green) and centromeres (red). (e)
An enlarged image of the boxed area in d showing YFP-HP1 (green) and
centromeres (red). Scale bar, 10 µm.
|